Predictors of galcanezumab response in a real-world study of Korean patients with migraine

被引：0
|
作者：
Kim, Seung Ae [1 ]
Lee, Mi Ji [1 ]
Jang, Hyemin [2 ]
机构：
[1] Seoul Natl Univ, Seoul, South Korea
[2] Samsung Med Ctr, Seoul, South Korea
来源：
CEPHALALGIA | 2023年 / 43卷 / 1supp期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC23-PO-2
引用
收藏
页码：222 / 223
页数：2
相关论文
共 50 条
  • [31] Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy
    Maurizi, Niccolo
    Chiriatti, Chiara
    Fumagalli, Carlo
    Targetti, Mattia
    Passantino, Silvia
    Antiochos, Panagiotis
    Skalidis, Ioannis
    Chiti, Chiara
    Biagioni, Giulia
    Tomberli, Alessia
    Giovani, Sara
    Coppini, Raffaele
    Cecchi, Franco
    Olivotto, Iacopo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (07)
  • [32] Real-world data on erenumab interruption in migraine patients in Germany: the SPECTRE study
    Gaul, Charly
    Goebel, Hartmut
    Koch, Mirja
    Weiss, Cordula
    CEPHALALGIA, 2023, 43 (1supp) : 232 - 233
  • [33] Effectiveness of galcanezumab on sleep quality, migraine outcome, and multidimensional patient-reported outcome measures: a real-world experience in Turkish patients with episodic and chronic migraine
    Ilgaz Aydinlar, Elif
    Erdogan Soyukibar, Tuba
    Yalinay Dikmen, Pinar
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [34] Switching anti-CGRP monoclonal antibodies in chronic migraine: real-world observations of erenumab, fremanezumab and galcanezumab
    Talbot, Jamie
    Stuckey, Rebecca
    Wood, Natasha
    Gordon, Alexander
    Crossingham, Ginette
    Weatherby, Stuart
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024,
  • [35] Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study
    Gladstone, Jonathan
    Chhibber, Sameer
    Minhas, Jagdeep
    Neish, Calum S.
    Power, G. Sarah
    Lan, Zhiyi
    Rochdi, Driss
    Lanthier-Martel, Jessica
    Bastien, Natacha
    HEADACHE, 2022, 62 (01): : 78 - 88
  • [36] Real-world Experience with Galcanezumab for the Preventive Treatment of Cluster Headache
    Cho, S. J.
    Mo, H.
    Moon, H. S.
    Kim, B. K.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [37] A Real-World Comparison of Erenumab and Galcanezumab in a Tertiary Headache Center
    Pham, A.
    Burch, R.
    HEADACHE, 2020, 60 : 4 - 5
  • [38] Real-world economic impact of onabotulinumtoxina in patients with chronic migraine
    JF Rothrock
    LM Bloudek
    TT Houle
    D Andress-Rothrock
    C Hanlon
    SF Varon
    The Journal of Headache and Pain, 2013, 14
  • [39] PREDICTORS OF RESPONSE IN PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH INFLIXIMAB OR GOLIMUMAB IN A REAL-WORLD SETTING
    Bessette, L.
    Kapur, S.
    Zummer, M.
    Starr, M.
    Choquette, D.
    Sheriff, M.
    Olszynski, W.
    Rampakakis, E.
    Psaradellis, E.
    Osborne, B.
    Maslova, K.
    Nantel, F.
    Lehman, A. J.
    Tkaczyk, C. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1131 - 1131
  • [40] Predictors of Response in Patients with Ankylosing Spondylitis Treated with Infliximab or Golimumab in a Real-World Setting
    Bessette, Louis
    Kapur, Suneil
    Zummer, Michel
    Starr, Michael
    Choquette, Denis
    Sheriff, Maqbool
    Olszynski, Wojciech
    Rampakakis, Emmanouil
    Psaradellis, Eliofotisti
    Osborne, Brendan
    Maslova, Karina
    Nantel, Francois
    Lehman, Allen
    Tkaczyk, Cathy
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1197 - 1197
12345